Journal of Oncology / 2009 / Article / Tab 4

Research Article

A Population-Based Clinical Trial of Irinotecan and Carboplatin

Table 4

Tumor types and best response to treatment. PR: partial response; SD: stable disease; PD: progressive disease; NA: not assessable.

Tumor typesNumber of patients
TotalPRSDPDNA

Nonsmall-cell lung215736
Small-cell lung104321
Gastrointestinal103322
Head and neck30120
Miscellaneous61311

Total5013171010

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.